RLE benefits most eyes

Article

In most eyes, the benefits of refractive lens exchange (RLE) outweigh the risks and it can provide a large improvement in patient quality of life, David Hardten said.

In most eyes, the benefits of refractive lens exchange (RLE) outweigh the risks and it can provide a large improvement in patient quality of life, David Hardten said.

"One patient told me 'This surgery has had a more positive impact on my quality of life than anything I've ever done for myself'. That's how big a difference it can make," Dr Hardten remarked.

Dr Hardten noted that quality of life metrics can be hard to establish. "There are no quality of life surveys specifically for refractive lens exchange, but some other studies show that there is a link between improved vision and quality of life."

He cited a Quality of Life Impact of Refractive Correction (QIRC) Questionnaire paper that showed lower satisfaction in patients in contact lenses and glasses than refractive surgery (Pesudovs, et al., JRS 2006;22:19).

Another survey using the National Eye Institute - Refractive Error Quality of Life (NEI-RQL) instrument found that emmetropes experienced the greatest quality of life, post-refractive patients came second, while those using presbyopic glasses had the least quality of life (Hays, et al., Ophth. 2003;110:2292).

Dr Hardten remarked that RLE provided many advantages over alternative refractive solutions. He noted that, with glasses there was a higher incidence of re-do's, while contact lenses had a higher incidence of re-fits. There were higher complications with radial keratotomy (RK), automated lamellar keratoplasty (ALK), LASIK, photorefractive keratectomy (PRK).

But with RLE people with reduced vision experience less handicap because there is less handicap because of less dependence on glasses and contact lenses, there is less magnification or minification of images than spectacles, and the risks associated with contact lenses are minimized.

Furthermore, there's no risk of future cataract development and there are a large variety of RLE IOLs available to today's surgeon, including monofocal, aspheric, monovision and presbyopic.

"You also get high quality outcomes," he concluded.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.